A reliable and cost-effective clinical research destination in the South Caucasus
Armenia is an increasingly attractive destination for international clinical research. Its capital Yerevan hosts several major university hospitals and specialist centres with internationally trained medical staff, making it an ideal location for Phase II–IV clinical trials across a wide range of therapeutic areas.
aCROss Medical has established a robust site network in Armenia, with experienced principal investigators and institutional relationships built over many years. Our local team manages all aspects of study operations — from regulatory submission and ethics approval to monitoring, data management and pharmacovigilance — ensuring high-quality delivery at competitive cost.
Clinical trials in Armenia are regulated by the Ministry of Health of the Republic of Armenia. The country has adopted GCP standards aligned with ICH E6(R2) guidelines, and data from Armenian sites has been accepted in regulatory submissions to both the US FDA and the European Medicines Agency. Ethics committee reviews are managed at the institutional level through established, independent committees.
Our Armenian investigative sites have a strong track record in cardiology, neurology, endocrinology, rheumatology, orthopaedics and oncology. The country's academic medical centres combine clinical expertise with research infrastructure that meets international standards for data quality and patient safety.
aCROss Medical's Armenia team includes dedicated CRAs, regulatory specialists and project managers who are on the ground and available to sponsors throughout the study. We handle all local logistics, site management, monitoring and reporting so that sponsors receive a seamless, transparent experience.